EUVIMEDEUVIMED entdecken
Crossref

METTL16 promotes colorectal cancer progression and CD8+ T cell function through BCAT1-dependent branched-chain amino acid metabolism

Yanyan Hu, Shengying Li, Minjing Zhu, Xuedan Lin, Chaoju Gong, Zejun Fang iD

Medical Oncology · 2026

DOI: 10.1007/s12032-026-03410-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Yanyan Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Sanmen People's Hospital, Sanmen, China. Hauptthemen laut MEDLINE: Transaminases, Colorectal Neoplasms, Amino Acids, Branched-Chain, CD8-Positive T-Lymphocytes. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Medical and Health Science and Technology Plan, Zhejiang Provincial County Level Advantageous Disciplines of Traditional Chinese Medicine Construction Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aims to investigate whether Methyl-Transferase-Like Protein 16 (METTL16) promotes colorectal cancer (CRC) progression through regulating branched-chain amino acid (BCAA) transaminase 1 (BCAT1)-mediated metabolism to modulate CD8+T cell-mediated anti-tumor immunity. METTL16 levels were measured in clinical CRC samples and cell models using IHC, qPCR and western blot. Functional assays (CCK-8, EdU, wound healing, transwell) were performed to evaluate the impact of METTL16 knockdown on CRC cell behaviors. A co-culture system with CD8+T cells was established to assess immune evasion mechanisms. RIP, MeRIP, and mRNA stability assays were conducted to explore METTL16's regulation of BCAT1 via m6A modification. Metabolomics analysis using LC-MS/MS quantified branched-chain amino acids (BCAAs). In vivo experiments utilized a xenograft mouse model to validate findings. METTL16 was elevated in CRC. Knockdown of METTL16 suppressed malignant phenotype of CRC cell, while enhancing CD8+T cell proliferation and cytotoxic molecule secretion (IFN-γ, IL-2, and GzmB). METTL16 regulated BCAT1 expression through m6A-dependent mRNA stabilization, promoting BCAAs metabolism. Rescue experiments demonstrated that BCAT1 overexpression reversed the regulation of METTL16 knockdown on tumor cell malignancy and CD8+ T cell responses. In vivo, METTL16 depletion inhibited tumor growth, reduced Ki-67 expression, and enhanced CD8+T cell infiltration and effector molecule levels. METTL16 drives CRC progression by promoting BCAT1-mediated BCAAs metabolism and facilitating immune evasion through suppression of CD8+T cell function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransaminasesColorectal NeoplasmsAmino Acids, Branched-ChainCD8-Positive T-LymphocytesMethyltransferasesHumansAnimalsMiceDisease ProgressionCell ProliferationFemaleCell Line, TumorRNA Methylation

Stichwörter der Autor:innen

BCAT1Branched chain amino acid metabolismCD8+T cellsColorectal cancerMETTL16

Substanzen

TransaminasesBCAT1 protein, humanAmino Acids, Branched-ChainMethyltransferases

Autor:innen und Institutionen

  • Clinical Laboratory, Sanmen People's Hospital, Sanmen, China.
  • Office of Drug Clinical Trial Institutions, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, China.
  • Central Laboratory, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, No. 19 Zhongshan Bei Road, Xuzhou, 221100, China. gongcj@zju.edu.cn.
  • Central Laboratory, Sanmen People's Hospital, No. 15 Taihe Road, Hairun Street, Sanmen, 317100, China. fangzejun@zjsmyy.com.

ORCID-Profile: Zejun Fang

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Medical and Health Science and Technology Plan
  • Zhejiang Provincial County Level Advantageous Disciplines of Traditional Chinese Medicine Construction Plan

Zitieren

APA

Hu, Y., Li, S., Zhu, M., Lin, X., Gong, C., & Fang, Z. (2026). METTL16 promotes colorectal cancer progression and CD8+ T cell function through BCAT1-dependent branched-chain amino acid metabolism. Medical Oncology. https://doi.org/10.1007/s12032-026-03410-7

Vancouver

Hu Y, Li S, Zhu M, Lin X, Gong C, Fang Z. METTL16 promotes colorectal cancer progression and CD8+ T cell function through BCAT1-dependent branched-chain amino acid metabolism. Medical Oncology. 2026. doi:10.1007/s12032-026-03410-7

BibTeX
@article{Hu2026,
  author = {Hu, Yanyan and Li, Shengying and Zhu, Minjing and Lin, Xuedan and Gong, Chaoju and Fang, Zejun},
  title = {METTL16 promotes colorectal cancer progression and CD8+ T cell function through BCAT1-dependent branched-chain amino acid metabolism},
  journal = {Medical Oncology},
  year = {2026},
  doi = {10.1007/s12032-026-03410-7}
}
Kostenlos starten →